Molecular genetics of the platelet serotonin system in first-degree relatives of patients with autism
Molecular genetics of the platelet serotonin system in first-degree relatives of patients with autism
复制标题
DOI:
10.1038/sj.npp.1301406
复制
发表时间:
2008-01-01
影响因子:
7.6
通讯作者:
Veenstra-VanderWeele, Jeremy
中科院分区:
文献类型:
--
作者:
Cross, Sarah;Kim, Soo-Jeong;Veenstra-VanderWeele, Jeremy
Elevated platelet serotonin (5-hydroxytryptamine, 5-HT) is found in a subset of children with autism and in some of their first-degree relatives. Indices of the platelet serotonin system, including whole blood 5-HT, 5-HT binding affinity for the serotonin transporter (K-m), 5-HT uptake (V-max), and lysergic acid diethylamide (LSD) receptor binding, were previously studied in 24 first-degree relatives of probands with autism, half of whom were selected for elevated whole blood 5-HT levels. All subjects were then genotyped for selected polymorphisms at the SLC6A4, HTR7, HTR2A, ITGB3, and TPH1 loci. Previous studies allowed an a priori prediction of SLC6A4 haplotypes that separated the subjects into three groups that showed significantly different 5-HT binding affinity (K-m, p = 0.005) and 5-HT uptake rate (V-max, p = 0.046). Genotypes at four individual polymorphisms in SLC6A4 were not associated with platelet 5-HT indices. Haplotypes at SLC6A4 and individual genotypes of polymorphisms at SLC6A4, HTR7, HTR2A, ITGB3, and TPH1 showed no significant association with whole blood 5-HT. Haplotype analysis of two polymorphisms in TPH1 revealed a nominally significant association with whole blood 5-HT (p = 0.046). These initial studies of indices of the 5-HT system with several single-nucleotide polymorphisms at loci in this system generate hypotheses for testing in other samples.